CorMedix IncNASDAQ:CRMD
- LAST PRICE5.2400
- TODAY'S CHANGE (%)-0.0300 (-0.5693%)
- Bid / Lots5.1600/ 1
- Ask / Lots5.3700/ 11
- Open / Previous Close5.3600 / 5.2700
- Day Range
- 52 Week Range
- Volume354,900
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRMD |
|---|---|---|
| 09:32 ET | 5197 | 5.3 |
| 09:36 ET | 1224 | 5.35 |
| 09:38 ET | 1819 | 5.36 |
| 09:39 ET | 750 | 5.375 |
| 09:41 ET | 5163 | 5.37 |
| 09:43 ET | 1054 | 5.36 |
| 09:45 ET | 200 | 5.365 |
| 09:48 ET | 200 | 5.3698 |
| 09:50 ET | 1068 | 5.36 |
| 09:52 ET | 2287 | 5.34 |
| 09:54 ET | 4148 | 5.315 |
| 09:57 ET | 738 | 5.3 |
| 09:59 ET | 500 | 5.31 |
| 10:01 ET | 1757 | 5.315 |
| 10:03 ET | 473 | 5.32 |
| 10:06 ET | 100 | 5.33 |
| 10:08 ET | 210 | 5.34 |
| 10:10 ET | 183 | 5.33 |
| 10:12 ET | 2113 | 5.33 |
| 10:14 ET | 100 | 5.34 |
| 10:15 ET | 200 | 5.335 |
| 10:17 ET | 435 | 5.33 |
| 10:21 ET | 100 | 5.32 |
| 10:28 ET | 115 | 5.32 |
| 10:30 ET | 200 | 5.315 |
| 10:32 ET | 650 | 5.304 |
| 10:33 ET | 137 | 5.3 |
| 10:35 ET | 3000 | 5.2911 |
| 10:37 ET | 1164 | 5.28 |
| 10:39 ET | 300 | 5.28 |
| 10:42 ET | 600 | 5.29 |
| 10:44 ET | 600 | 5.295 |
| 10:46 ET | 728 | 5.3 |
| 10:48 ET | 145 | 5.3 |
| 10:50 ET | 4389 | 5.295 |
| 10:53 ET | 100 | 5.3 |
| 10:55 ET | 487 | 5.29 |
| 11:06 ET | 200 | 5.29 |
| 11:08 ET | 100 | 5.29 |
| 11:09 ET | 4202 | 5.3 |
| 11:13 ET | 500 | 5.3 |
| 11:15 ET | 1000 | 5.3101 |
| 11:18 ET | 300 | 5.31 |
| 11:20 ET | 1014 | 5.315 |
| 11:22 ET | 2306 | 5.32 |
| 11:24 ET | 19556 | 5.31 |
| 11:26 ET | 400 | 5.29 |
| 11:27 ET | 482 | 5.29 |
| 11:29 ET | 2026 | 5.31 |
| 11:31 ET | 1050 | 5.3 |
| 11:33 ET | 731 | 5.277 |
| 11:36 ET | 19165 | 5.25 |
| 11:40 ET | 100 | 5.255 |
| 11:42 ET | 500 | 5.25 |
| 11:44 ET | 500 | 5.245 |
| 11:45 ET | 1900 | 5.245 |
| 11:47 ET | 6613 | 5.27 |
| 11:49 ET | 3926 | 5.265 |
| 11:51 ET | 400 | 5.265 |
| 11:54 ET | 522 | 5.265 |
| 11:56 ET | 2937 | 5.26 |
| 11:58 ET | 100 | 5.265 |
| 12:00 ET | 400 | 5.25 |
| 12:02 ET | 1600 | 5.25 |
| 12:03 ET | 200 | 5.25 |
| 12:07 ET | 235 | 5.24 |
| 12:12 ET | 1768 | 5.235 |
| 12:14 ET | 794 | 5.22 |
| 12:16 ET | 519 | 5.22 |
| 12:18 ET | 600 | 5.22 |
| 12:23 ET | 1611 | 5.2199 |
| 12:25 ET | 370 | 5.225 |
| 12:27 ET | 300 | 5.22 |
| 12:34 ET | 8010 | 5.22 |
| 12:38 ET | 1045 | 5.225 |
| 12:39 ET | 681 | 5.235 |
| 12:41 ET | 300 | 5.23 |
| 12:43 ET | 1350 | 5.235 |
| 12:50 ET | 1103 | 5.224 |
| 12:56 ET | 2000 | 5.215 |
| 12:57 ET | 2200 | 5.22 |
| 01:01 ET | 1725 | 5.21 |
| 01:08 ET | 100 | 5.205 |
| 01:10 ET | 3436 | 5.205 |
| 01:12 ET | 30703 | 5.173 |
| 01:15 ET | 18121 | 5.16 |
| 01:17 ET | 706 | 5.17 |
| 01:19 ET | 854 | 5.18 |
| 01:21 ET | 200 | 5.17 |
| 01:24 ET | 200 | 5.185 |
| 01:26 ET | 645 | 5.19 |
| 01:28 ET | 794 | 5.18 |
| 01:30 ET | 100 | 5.19 |
| 01:32 ET | 200 | 5.19 |
| 01:33 ET | 100 | 5.19 |
| 01:35 ET | 369 | 5.18 |
| 01:37 ET | 200 | 5.17 |
| 01:39 ET | 200 | 5.17 |
| 01:44 ET | 202 | 5.17 |
| 01:48 ET | 800 | 5.17 |
| 01:50 ET | 800 | 5.17 |
| 01:51 ET | 200 | 5.1666 |
| 01:57 ET | 900 | 5.16 |
| 02:00 ET | 3281 | 5.165 |
| 02:02 ET | 200 | 5.165 |
| 02:06 ET | 1000 | 5.1601 |
| 02:08 ET | 10016 | 5.1501 |
| 02:09 ET | 1049 | 5.17 |
| 02:11 ET | 2600 | 5.1733 |
| 02:15 ET | 1362 | 5.175 |
| 02:18 ET | 2883 | 5.175 |
| 02:20 ET | 800 | 5.1799 |
| 02:22 ET | 1263 | 5.19 |
| 02:24 ET | 700 | 5.18 |
| 02:33 ET | 100 | 5.185 |
| 02:36 ET | 520 | 5.18 |
| 02:40 ET | 123 | 5.175 |
| 02:42 ET | 6732 | 5.17 |
| 02:44 ET | 100 | 5.17 |
| 02:45 ET | 400 | 5.165 |
| 02:47 ET | 100 | 5.17 |
| 02:49 ET | 400 | 5.17 |
| 02:51 ET | 200 | 5.16 |
| 02:54 ET | 1000 | 5.16 |
| 02:56 ET | 100 | 5.155 |
| 03:00 ET | 1085 | 5.16 |
| 03:02 ET | 3166 | 5.155 |
| 03:03 ET | 1000 | 5.16 |
| 03:05 ET | 593 | 5.16 |
| 03:09 ET | 531 | 5.17 |
| 03:14 ET | 400 | 5.18 |
| 03:16 ET | 1300 | 5.2 |
| 03:18 ET | 100 | 5.205 |
| 03:27 ET | 221 | 5.2 |
| 03:30 ET | 374 | 5.195 |
| 03:32 ET | 1243 | 5.19 |
| 03:34 ET | 474 | 5.195 |
| 03:36 ET | 1000 | 5.2 |
| 03:38 ET | 2439 | 5.225 |
| 03:39 ET | 310 | 5.225 |
| 03:41 ET | 4311 | 5.215 |
| 03:43 ET | 100 | 5.21 |
| 03:45 ET | 621 | 5.215 |
| 03:48 ET | 2743 | 5.22 |
| 03:50 ET | 704 | 5.225 |
| 03:52 ET | 1876 | 5.215 |
| 03:54 ET | 1051 | 5.215 |
| 03:56 ET | 6526 | 5.225 |
| 03:57 ET | 4650 | 5.24 |
| 03:59 ET | 27276 | 5.24 |
May 28, 2024
CorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis Provider, from 8:30AM ET on Tuesday May 28, 2024 by Dow Jones
8:30AM ET on Tuesday May 28, 2024 by Dow Jones
May 13, 2024
DJ CorMedix Price Target Maintained With a $10.00/Share by Needham, from 5:42AM ET on Monday May 13, 2024 by Dow Jones
5:42AM ET on Monday May 13, 2024 by Dow Jones
May 10, 2024
CorMedix Inc. to Participate in Two Upcoming Investor Conferences, from 8:30AM ET on Friday May 10, 2024 by Dow Jones
8:30AM ET on Friday May 10, 2024 by Dow Jones
May 9, 2024
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update, from 7:30AM ET on Thursday May 09, 2024 by Dow Jones
7:30AM ET on Thursday May 09, 2024 by Dow Jones*DJ CorMedix 1Q Loss/Shr 25c >CRMD, from 7:30AM ET on Thursday May 09, 2024 by Dow Jones
7:30AM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CorMedix Inc | 289.8M | -5.6x | --- |
Cipla Ltd | 14.0B | 0.0x | --- |
Zevra Therapeutics Inc | 194.6M | -3.6x | --- |
Calliditas Therapeutics AB | 1.2B | -21.2x | --- |
Assembly Biosciences Inc | 83.5M | -1.3x | --- |
Dbv Technologies SA | 119.3M | -0.7x | --- |
Company Information
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.
Contact Information
- Headquarters
- 300 Connell Drive, Suite 4200BERKELEY HEIGHTS, NJ, United States 07922
- Phone
- 908-517-9500
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Myron Kaplan
- Chief Executive Officer, Director
- Joseph Todisco
- Chief Financial Officer, Executive Vice President
- Matthew David
- Executive Vice President, Head of Clinical and Medical Affairs
- Elizabeth Massonhurlburt
- Executive Vice President, Chief Commercial Officer
- Erin Mistry
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $289.8M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 55.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.73 |
EPS | $-0.93 |
Book Value | $1.28 |
P/E Ratio | -5.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
